Babcock & Wilcox Enterprises Inc buy krebskrebs
Start price
28.04.20
/
50%
€0.86
Target price
04.11.21
€0.90
Performance (%)
666.08%
End price
05.11.21
€6.55
Summary
This prediction ended on 05.11.21 with a price of €6.55. With a performance of 666.08% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Babcock & Wilcox Enterprises Inc | -9.043% | -9.043% | -84.732% | -86.320% |
iShares Core DAX® | 1.804% | -0.748% | 13.168% | 16.408% |
iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% | 43.502% |
iShares Nikkei 225® | 0.413% | -7.381% | 18.776% | 2.874% |
iShares S&P 500 | 0.664% | -1.941% | 28.141% | 42.155% |
Comments by krebskrebs for this prediction
In the thread Babcock & Wilcox Enterprises Inc diskutieren
Buy mit Kursziel 0,9
In the thread Trading Babcock & Wilcox Enterprises Inc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten